FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

425874004: Hydroxyapatite (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2661149011 Hydroxyapatite (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    2673674016 Hydroxyapatite en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Hydroxyapatite Is a Mineral supplement false Inferred relationship Existential restriction modifier
    Hydroxyapatite Is a Calcium phosphate false Inferred relationship Existential restriction modifier
    Hydroxyapatite Is a Phosphate salt false Inferred relationship Existential restriction modifier
    Hydroxyapatite Is a Calcium compound false Inferred relationship Existential restriction modifier
    Hydroxyapatite Is a Stone constituent false Inferred relationship Existential restriction modifier
    Hydroxyapatite Is modification of Calcium phosphate false Inferred relationship Existential restriction modifier
    Hydroxyapatite Is a Phosphate false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Hydroxyapatite Is a False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing durapatite (medicinal product) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Hydroxyapatite Is modification of False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing durapatite in oral dose form (medicinal product form) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has precise active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has basis of strength substance False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Hydroxyapatite Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing only durapatite in parenteral dose form (medicinal product form) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 2
    Product containing durapatite in parenteral dose form (medicinal product form) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
    Product containing carmellose and durapatite (medicinal product) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 2
    Product containing only carmellose and durapatite (medicinal product) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 2
    Product containing only carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 2
    Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Hydroxyapatite 3.32g granules sachets sugar free 28 sachet Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) 28 sachet Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Ossopan 800 tablets (Sanofi-Synthelabo Ltd) 50 tablet 5 x 10 tablets Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Ossopan 800 tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Hydroxyapatite 830mg tablets 50 tablet Has specific active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Ossopan 800 tablets (Sanofi-Synthelabo Ltd) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
    Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start